.Net Develop Report Thousand Oaks 
socalTECH
OCTOBER 1, 2013
Thousand Oaks-based Amgen reported this morning that it has completed its tender offer for Onyx Pharmaceuticals , and now expects its acquisition to complete today. billion net of estimated cash at Onyx. Amgen said the deal is worth $9.7
socalTECH
JANUARY 27, 2011
In a sign that Thousand Oaks-based Nexsan might be ramping up its IPO efforts again, after a delay last year, the firm filed an updated S-1 this week. The provider of data storage equipment reported that it had net income of $0.5M in net income of $19.28M in revenues for the three months ended September 30, 2010.
Xconomy
AUGUST 26, 2016
—Amgen (NASDAQ: AMGN ) of Thousand Oaks, CA, said that the FDA rejected its drug etelcalcetide (Parasbiv) , a treatment for patients with an excess of damaging hormone release because of chronic kidney disease. Alex Lash contributed to this report. Morgan party. Reprints | Share: UNDERWRITERS AND PARTNERS.
Expert insights. Personalized for you.
173 
Let's personalize your content